ABSTRACT
Albendazole is a benzimidazole carbamate anthelmintic that was originally synthesized by Smith Kline and French Animal Health. It was initially developed as a veterinary anthelmintic but subsequently was registered for human use in 1982. It is currently marketed as Zentel/Eskazole (Albenza in the United States) by the originators, although a very large number of generic products are available, especially in developing countries.
